Joel P. Arrais
Name of the talk: Deep Learning techniques for drug discovery
In this talk I will present a walkthrough on the creation of a computational pipeline that uses Bioinformatics methods allied with Deep Learning architectures to support the drug discovery process. Deep networks were proven to be more effective than shallow architectures to face complex problems like speech or image recognition. In addition, deep architectures are able to amplify key discriminative aspects from the input data while suppressing irrelevant information, thus attaining improved accuracy. However, the efficient implementation to the domain of Drug Discovery is still at an early stage.
"I am an Assistant Professor at the Department of Informatics Engineering, University of Coimbra, since 2012. I have received my MSc and PhD in Computer Science from University of Aveiro in 2004 and 2010 respectively. My research interest are on developing algorithms to model biological problems. I'm particularly interested in using pattern recognition and machine learning methods. On the recent past I have been involved on several studies that focused on the analysis and knowledge extraction from gene-expression data."
Name of the talk: Bioreactors for stem cells expansion and differentiation
The use of stem cells within biomedical applications in the development of disease models and, in the future, regenerative and precision medicine is very promising, specially in tissue engineering. However, these applications require large amounts of cells that can be created in in vitro cultures using bioreactors. This presentation will show both the importance and potential of this tecnology.
Carlos Rodrigues is a Master in Biological Engineering through Instituto Superior Técnico (IST) - Universidade de Lisboa, where he also earned his PhD on Stem Cells Bioengineering, more specifically on the expansion of neural stem cells. Currently he's a researcher on Instituto de Bioengenharia and Biosciences (iBB) and Auxiliary Guest Professor on IST. The main topics of his research are the development and operation of culture systems for human pluripotent stem cells with a view to its expansion and cardiac differentiation using bioreactor technology and biomaterials.
Name of the talk: Intelligent Lab on Fiber: how photonics and AI are accelerating personalised therapies.
In this talk, the speaker will focus on the work he has been developing as a biomedical engineer on said laboratory and elaborate on the contribution made by iLoF to solve some of the medical field's greatest challenges, showing why iLoF's one of the best european companies in its area.
In 2016, Simão became a Master in Biomedical Engineering - Bioengeneering through FEUP. In the same year, he integrated INESC Tec's laboratory team as a researcher, where he worked within the topic of Automatic thickness measurement of the choroidal thickness on C-BER (Biomedical Imaging Lab). Posteriorly, he was part of other laboratory teams within the area of Artificial Intelligence and Data Science. Currently he's the Tech Lead of iLoF's Data Science Team, a company that, through photonics and artifical intelligence, elaborated a cloud based-library constituted by biomarkers of diseases and biological profiles as a way of creating visualization and stratification tools, both quick and easy to allocate.
Name of the talk: BioMark: new sensing materials with application in medical contexts
This talk will present the scientific advances developed within the 2IQBioNeuro project, whose goal is the development of disposable sensors for early diagnosis of Alzheimer's Disease.
This talk will present the scientific advances developed within the 2IQBioNeuro project, whose goal is the development of disposable sensors for early diagnosis of Alzheimer's Disease.Bachelor in Chemical Engineering through Instituto Superior de Engenharia do Porto and Master in Technology, Science and Food Security through Faculdade de Ciencias da Universidade do Porto. She earned her PhD in Sustainable Chemistry through Faculdade de Ciências e Tecnologia da Universidade NOVA de Lisboa. Felismina's background experience comes from the area of biosensors with either electrical or stained transduction and she also has a lot of experience in the development of new materials for the recognition of a wide variety of compounds.
In 2014, Felismina was granted a post-doctoral fellowship supported by Fundação para Ciência e Tecnologia (SFRH/BPD/97891/2013) with the title "Development of biomedical devices for the rapid detection of Alzheimer's disease's biomarkers". This project was developed on BioMark Sensor Research/ISEP with the collaboration of Imperial College London/UK's Chemistry Department and Biomedical Engineering Institute and Universidade de Aveiro's Cell Biology Center (CBC). She was also a Guest Professor in Escola de Saúde do Instituto Politécnico do Porto where she taught Biosensors to 3rd year Medicinal Biotechnology students. Currently she coordinates the BioMark/ISEP group holding a PhD researcher position.
Name of the talk: Fibers and nanomaterials for personal protection equipments
Fibrenamics was ahead on its competitors with the development of white book for individual protection devices during the pandemic. The speaker Raúl Fangeiro will share his perspective and personal experience within the area of fiber and nanomaterials with a focus on personal protection equipment.
Raúl Fangeiro is a teacher and researcher at Escola de Engenharia da Universidade do Minho, where he’s the Departamento de Engenharia Mecânica’s Director. He’s the coordinator of Fibrous Materials Research Group, a group composed of around 40 other researchers that works with materials (such as nanomaterials, smart and composites) and advanced structures (such as 3D and auxetics). He’s also the General Coordinator and mentor of Fibrenamics, a platform which purpose is the generation, valorization and transfer of knowledge. Fibrenamics has more than 350 partners and was recognized by the European Comission as a ‘case study’ due to its university-company relation.
Raúl has published more than 165 articles in international scientific magazines, has participated in more than 500 conferences, autored 36 books and chapters and has 40 patents. He usually coordinates national or international I&D projects and supervises different doctorate and post-doctorate works in different countries, working as the scientific coordinator of AUXDEFENSE’s international conferences. He’s also the mentor and coordinator of WANFR (World Association of Natural Fibers Research), colaborator on many scientific magazines and member of work groups within the European Defense Agency and NATO.
Name of the talk: Trans-Energy Multimodal Imaging: from Development to Commercial Products via Clinical Translation
Trans-energetic image modalities have been significantly explored to overcome the problems that exist in conventional image modalities regarding spatial-temporal resolutions, depth of penetration, signal-to-noise ratio, contrast, among others. Among them, the photoacoustic image stands out, an emerging hybrid modality that can provide strong contrasts of endogenous and exogenous optical absorption with high ultrasonic spatial resolution and that overcomes the fundamental depth limitation, maintaining spatial resolution. The image resolution, as well as the maximum image depth, is scalable with ultrasonic frequency within the range of diffuse photons. In this presentation, multiscale and multiparametric trans-energetic image systems, new image processing pipelines through deep learning, results of recent clinical studies and the efforts to commercialize these systems will be presented.
Dr. Chulhong Kim did his PhD and post-doctorate under the supervision of Prof. Lihong Wang at Washington University in St. Louis. He currently holds the position of Mueunjae Chair Professorship in Electrical Engineering, IT Convergence Engineering and Mechanical Engineering at Pohang University of Science and Technology in the Republic of Korea and Director of the POSTEH Medical Device Innovation Center (supported by the Ministry of Korean Education). He is the CEO of Opticho Inc., a spin-off company that commercializes preclinical and clinical photoacoustic imaging systems.
Name of the talk: Life Science Megatrends Shaping Our Future
Technology leadership based on a culture of innovation, contribution and sustained investment in R&D has been at the heart of Agilent's success over decades of technology and market cycles. Nowadays, biology is the field where science and understanding change most quickly. This talk will highlight the major megatrends in this ‘century of biology’ and some of the technology contributions under development at Agilent that will underpin tomorrow’s discoveries.
Dr. Darlene Solomon is senior vice president and CTO at Agilent Technologies. Her responsibilities include Agilent's research labs, focused on high-impact, long-range research to support the sustained growth of Agilent's business, and Agilent's programs with universities, external research and risky investments. In her leadership role, she works closely with Agilent's businesses to define the company's technology strategy and R&D priorities.
She started at Hewlett-Packard Laboratories in 1984 as a researcher and soon took the lead as Manager of Research and Development in the Department of Chemical and Biological Systems. When Agilent Technologies split from H-P in 1999, it became responsible for Research and Development / Technology for Agilent's Life Sciences and Chemical Analysis businesses. In 2003, she was promoted to Vice President and Director of Agilent Laboratories, and since 2006 she is Director of Technology and Senior Vice President of Agilent Technologies.
Darlene Solomon graduated in chemistry from Stanford University, obtained her doctorate in bioinorganic chemistry from MIT and completed the Stanford University Executive Development Program. Among the recognitions for her achievements, Solomon was elected to the National Academy of Engineering and received the Daniel J Epstein Award for Engineering Management from the USC Viterbi School of Engineering. She was also elected a Fellow of the American Institute of Medical and Biological Engineering, included in the Women in Technology International Hall of Fame, recipient of the YWCA Tribute to Women and Industry award and nominated for Corporate Board Member's 50 Top Women in Technology.
Solomon is on the board of directors of Materion Corporation. She also serves on various academic and government advisory and review boards, which include nominations for National Academies' Board on Chemical Sciences and Technology, Visiting Committee on Advanced Technology of the National Institutes of Standards and Technology, Stanford Interdisciplinary Life Sciences Council, UC Berkeley's College of Engineering Advisory Board, and Singapore National Research Foundation's Scientific Advisory Board.